[Prevention of atherosclerosis using an antioxidant]

Area of Science:

• Cardiovascular Research
• Pharmacology
• Animal Models of Disease

Context:

• Familial hypercholesterolemia (FH) is characterized by elevated LDL cholesterol, a major atherosclerosis risk factor.
• Oxidized LDL promotes lipid accumulation in macrophages, contributing to atherogenesis.
• Probucol, an antioxidant, inhibits LDL oxidation in vitro and has shown clinical benefits in FH patients.

Purpose:

• To investigate the efficacy of probucol in preventing aortic atherosclerosis progression in homozygous WHHL rabbits.
• To evaluate the impact of probucol on atherosclerotic lesion development in an established animal model of FH.

Summary:

• WHHL rabbits treated with probucol (1 g/day) for 6 months showed significantly reduced aortic plaque area (7.0%) compared to controls (54.2%).
• Long-term probucol administration (16 months) also suppressed lesion progression, although some progression occurred in both groups.
• These findings suggest probucol's potent anti-atherosclerotic effects in vivo.

Impact:

• Probucol demonstrates significant potential in preventing and suppressing the progression of atherosclerosis.
• The study supports probucol as a therapeutic agent for conditions involving hyperlipidemia and oxidative stress.
• Results provide a basis for further research into probucol's mechanisms and clinical applications in cardiovascular disease.